报价延迟最少15分钟:2025/07/21 08:34 EDT
盘前时段
|
||||
|
4.5 
|
|
|
常规时段
|
|
|
|
|
||||||||||||
|
|
|
|
|
4.48
|
|
|
| 价值评估 |
|
盈利(现时/预测)
-4.61/-0.76
|
|
企业价值
5.96M
|
| 资产负债 |
|
每股账面净值
1.41
|
| 现金流量 |
|
现金流量率
--
|
| 损益表 |
|
收益
0
|
|
每股收益
0.04
|
|
同行比较
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
报价延迟最少15分钟：2025/07/21 08:34 EDT
同行比较之报价最少15分钟延迟
|
业务概览
|
|||
| Titan Pharmaceuticals Inc is a development stage company developing proprietary therapeutics with utilizing ProNeura long-term, continuous drug delivery technology. The ProNeura technology has the potential to be used in developing products for treating a number of chronic conditions, where maintaining consistent, around-the-clock blood levels of medication may benefit the patient and improve medical outcomes. |
